ArticleBMC pediatrics2023

Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy.

Yang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.